WeVote
Log In

Bill

Bill

HRES 601

Recognizing the duty of the Federal Government to lead the world in biomedical research.

119th Congress Introduced by Jake Auchincloss and 2 co-sponsors

HRES 601 urges the Federal Government to double biomedical research funding, enhance workforce support, and improve public health outcomes for all Americans.

Submitted in House
0
WeVote Research Nonpartisan
Bill Summary · HRES 601

Summary of HRES 601: Recognizing the Duty of the Federal Government to Lead the World in Biomedical Research

Bill Information:
- Bill Number: HRES 601
- Title: Recognizing the duty of the Federal Government to lead the world in biomedical research
- Status: Submitted in House
- Introduced: July 23, 2025
- Classification: Resolution

Purpose and Intent

HRES 601 expresses the sense of the House of Representatives regarding the importance of biomedical research in the United States. It emphasizes the need for the Federal Government to protect, improve, and expand the nation's biomedical research capabilities, asserting that such efforts are crucial for maintaining the U.S. leadership in global biomedical advancement and innovation.

Key Provisions

The resolution outlines several key provisions, including:

  1. National Asset Recognition: Biomedical research is identified as a national asset that requires protection and enhancement.

  2. Support for NIH: The National Institutes of Health (NIH) is recognized for its role in sustaining a robust biomedical research framework.

  3. Workforce Respect: The resolution calls for respect and fair compensation for the biomedical research workforce, including public servants at NIH.

  4. Whole-of-Government Approach: It advocates for a collaborative effort across the government to protect public health, starting with necessary research.

  5. Investment in Training and Retention: Federal support is deemed essential for:

    • Training new scientists.
    • Retaining premier scientists in the U.S.
    • Ensuring a stable and committed scientific workforce.

  6. Evidence-Based Decision Making: Scientific decisions should be based on peer-reviewed evidence, free from political interference.

  7. Doubling Investment: The resolution proposes that the Federal Government should double its investment in biomedical research over the next decade.

  8. Broad Research Support: Federal investments should support:

    • Basic and translational research.
    • High-risk, high-reward projects.
    • Collaborative resources and knowledge sharing.
    • Transparency and accountability in research.

  9. Quality of Life Improvements: The Federal Government is encouraged to invest in research aimed at:

    • Reversing declines in life expectancy.
    • Addressing microbial threats.
    • Understanding neurodegenerative diseases.
    • Reducing cancer mortality and improving quality of life for patients.
    • Preventing chronic diseases and improving health outcomes for underserved populations.

Affected Parties

The resolution impacts various stakeholders, including:
- Biomedical researchers and scientists.
- Public health officials and agencies.
- Patients and healthcare providers.
- Underserved populations who may benefit from improved health interventions.

Legislative Actions

  • July 23, 2025: The bill was referred to the House Committee on Energy and Commerce and submitted in the House.

Conclusion

HRES 601 seeks to reaffirm the Federal Government's commitment to biomedical research as a cornerstone of public health and innovation. By advocating for increased investment and support for the biomedical research workforce, the resolution aims to enhance the United States' role as a leader in scientific advancement and improve health outcomes for all Americans.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.